|
 The following presentations were shown at the
NABP 104th Annual Meeting in May 2008.
Teen Addiction – Prescription Medications: The New Heroin?
According to statistics, teen addiction to prescription pain medications is reaching catastrophic proportions. Meeting participants will review the issues associated with this problem, including sources of prescription drugs, the role the Internet plays, and strategies to assist in abuse prevention.
- Thomas A. Hedrick, Jr, BA
Senior Communications Officer and Founding Member
Partnership for a Drug-Free America
- Barbara Delaney, MBA
Director of Research
Partnership for a Drug-Free America
- Phil Bauer
Member, Parent Advisory Board
Partnership for a Drug-Free America
Parents, Kids and Drugs. Today’s Changing Landscape in Substance Abuse:
Adolescent Abuse of Rx & OTC Medicines
Legislative and Regulatory Update
Boards of pharmacy are continually faced with an assortment of legislative and regulatory issues. During this session, participants will review recent federal and state legislative and regulatory initiatives of interest to boards of pharmacy.
- Joshua M. Bolin, BA
State Relations Manager
NABP
State Regulatory Update
- Eileen Lewalski, PharmD, JD
Professional Affairs Manager
NABP
Federal Regulatory Update
Pedigree Update: RFID and Diversion from Common Carriers
As counterfeit drugs and devices and diversion continue to pose significant threats to the public health, the use of electronic tools is becoming increasingly common to counter this threat, as well as to optimize the efficiency and effectiveness of the drug distribution process. During this session, meeting participants will examine how industry and enforcement officials have incorporated such tools into their efforts.
- Ryan Toole
Supervisory Special Agent
Federal Bureau of Investigation
FBI Activities and Pharmaceutical Crime
- Ilisa Bernstein, PharmD, JD
Director of Pharmacy Affairs
Food and Drug Administration
Pedigree Update: RFID and Diversion
Medicaid Fraud: Tamper-Resistant Prescription Pads and Beyond
Centers for Medicare and Medicaid Services (CMS) representatives will discuss Congress’s findings pertaining to fraudulent activities in pharmacy and its efforts to combat such activities, as well as how boards of pharmacy may work with CMS in these efforts.
- Jason Weinstock, JD
Law Enforcement Coordinator
Centers for Medicare and Medicaid Services, Medicaid Integrity Group
An Overview of CMS’ Medicaid Integrity Program and An Update on the Implementation of the Tamper Resistant Prescription Paper Law
- Michael A. Burleson, RPh
Executive Director
Kentucky Board of Pharmacy
Kentucky Medicaid Tamper-Resistant Prescription Pad
Case Strategy: How to Investigate an Internet Pharmacy
Relentless solicitation efforts of an increasing number of rogue Internet “pharmacy” sites are placing the public health at risk. State boards of pharmacy, other state agencies, and the federal government must work together to put these sites out of business. During this session, meeting participants will examine and discuss strategies to build a case against an Internet pharmacy using all available resources.
- Benjamin N. Gluck, MA, JD
Partner and Shareholder
Bird, Marella, Boxer, Wolpert, Nessim, Drooks, and Lincenberg, A Professional Corporation
Case Strategy: How to Investigate an Internet Pharmacy
Compounding Update: Where is USP 797?
Meeting participants will examine the recent updates to the United States Pharmacopeia Chapter 797 sterile compounding standards.
- Claudia C. Okeke, PhD, RPh
Scientific Fellow
United States Pharmacopeia
USP Chapter <797>: Update on Recent Revisions
- Ruth K. Miller, JD
Senior Counsel
United States Pharmacopeia
USP General Chapter <797>: Legal/Regulatory Update
For links to sessions from the Fall Legislative Conference in September 2007 click here.
|
